Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goodman

Showing results (181-190 of 1,119) with videos related to

Pageof 112
Sort By:
The Journal of Experimental Medicine|April 1, 1981
T cell regulation of polyclonal B cell responsiveness. III. Overt T helper and latent T suppressor activities from distinct subpopulations of unstimulated splenic T cellsM G Goodman, W O Weigle
Advances in Renal Replacement Therapy|August 31, 2002
Future role of calcimimetics in end-stage renal diseaseWilliam G Goodman, Stewart A Turner
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1983
Activation of lymphocytes by a thiol-derivatized nucleoside: characterization of cellular parameters and responsive subpopulationsM G Goodman, W O Weigle
Cellular Immunology|October 15, 1989
Ligand binding sites for a synthetic B cell growth and differentiation factorM G Goodman, D M Cherry
Infection and Immunity|December 1, 1982
Mitogenic activity of Sindbis virus and its isolated glycoproteinsG Goodman-Snitkoff, J J McSharry
Current Opinion in Nephrology and Hypertension|May 9, 2001
Non-invasive assessments of cardiovascular disease in patients with renal failureW G Goodman, I B Salusky
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1980
Modulation of lymphocyte activation. I. Inhibition by an oxidation product of arachidonic acidM G Goodman, W O Weigle
Mineral and Electrolyte Metabolism|January 1, 1991
Renal osteodystrophy in dialyzed childrenI B Salusky, W G Goodman
Progress in Clinical and Biological Research|January 1, 1991
The relationship between carcinogenic potency and maximum tolerated dose is similar for mutagens and nonmutagensG Goodman, A Shlyakhter, R Wilson
Calcified Tissue International|August 31, 2015
Calcimimetic and Calcilytic Drugs: Feats, Flops, and FuturesE F Nemeth, W G Goodman
Pageof 112

Showing results (181-190 of 1,119) with videos related to

Sort By:
Pageof 112
The Journal of Experimental Medicine|April 1, 1981
T cell regulation of polyclonal B cell responsiveness. III. Overt T helper and latent T suppressor activities from distinct subpopulations of unstimulated splenic T cellsM G Goodman, W O Weigle
Advances in Renal Replacement Therapy|August 31, 2002
Future role of calcimimetics in end-stage renal diseaseWilliam G Goodman, Stewart A Turner
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1983
Activation of lymphocytes by a thiol-derivatized nucleoside: characterization of cellular parameters and responsive subpopulationsM G Goodman, W O Weigle
Cellular Immunology|October 15, 1989
Ligand binding sites for a synthetic B cell growth and differentiation factorM G Goodman, D M Cherry
Infection and Immunity|December 1, 1982
Mitogenic activity of Sindbis virus and its isolated glycoproteinsG Goodman-Snitkoff, J J McSharry
Current Opinion in Nephrology and Hypertension|May 9, 2001
Non-invasive assessments of cardiovascular disease in patients with renal failureW G Goodman, I B Salusky
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1980
Modulation of lymphocyte activation. I. Inhibition by an oxidation product of arachidonic acidM G Goodman, W O Weigle
Mineral and Electrolyte Metabolism|January 1, 1991
Renal osteodystrophy in dialyzed childrenI B Salusky, W G Goodman
Progress in Clinical and Biological Research|January 1, 1991
The relationship between carcinogenic potency and maximum tolerated dose is similar for mutagens and nonmutagensG Goodman, A Shlyakhter, R Wilson
Calcified Tissue International|August 31, 2015
Calcimimetic and Calcilytic Drugs: Feats, Flops, and FuturesE F Nemeth, W G Goodman
Pageof 112